Acknowledgement to Referees.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1487, doi. 10.1007/s40262-020-00958-z
- Publication type:
- Article
Works matching IS 03125963 AND DT 2020 AND VI 59 AND IP 12
Results: 13
1
2
Correction to: Drug-Drug Interactions with Direct Oral Anticoagulants.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
3
Author's Reply to Liu et al.: "Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab".
- Published in:
- 2020
- By:
- Publication type:
- Letter
4
Comment on "Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab".
- Published in:
- 2020
- By:
- Publication type:
- Letter
5
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1521, doi. 10.1007/s40262-020-00934-7
- By:
- Publication type:
- Article
6
Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019.
- Published in:
- 2020
- By:
- Publication type:
- journal article
7
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
8
Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1501, doi. 10.1007/s40262-020-00930-x
- By:
- Publication type:
- Article
9
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1627, doi. 10.1007/s40262-020-00907-w
- By:
- Publication type:
- Article
10
Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1611, doi. 10.1007/s40262-020-00904-z
- By:
- Publication type:
- Article
11
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog<sup>®</sup> (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1589, doi. 10.1007/s40262-020-00903-0
- By:
- Publication type:
- Article
12
Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1575, doi. 10.1007/s40262-020-00902-1
- By:
- Publication type:
- Article
13
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog<sup>®</sup> (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 12, p. 1601, doi. 10.1007/s40262-020-00901-2
- By:
- Publication type:
- Article